Kontakt

Dr. Sandra Hauser

Wissen­schaftliche Mitarbeiterin
Radio­pharma­zeutische und Chemische Bio­logie
s.hauserAthzdr.de
Tel.: +49 351 260 4046

Prof. Dr. Jens Pietzsch

Abtei­lungs­leiter
Radio­pharma­zeutische und Chemische Bio­logie
j.pietzschAthzdr.de
Tel.: +49 351 260 2622

Tissue Regeneration and Inflammation Imaging

The aim of this group is the development and validation of molecular imaging techniques for the investigation of inflammatory, fibrotic and carcinogenic processes. Our research consists of four main lines. First, we focus on the development of targeted compounds for the detection of early biomarkers of carcinogenesis, cancer progression or tissue regeneration, mainly by PET, SPECT and optical imaging. Secondly, selected compounds are tested for their suitability as cancer theranostics. Examples of such compounds are selective cyclooxygenase-2 inhibitors for both functional characterization and therapeutic modulation of inflammatory processes. Selective transglutaminase 2 inhibitors in turn address matrix-modifying processes. Third, we develop and study three-dimensional (3D) cell models and animal models for solid, in particular therapy-resistant tumors with a distinct inflammatory and/or fibrotic matrix-associated microenvironment to improve our understanding of the disease process. Examples are pancreatic ductal adenocarcinoma (PDAC) and hepatocellular carcinoma (HCC). Fourthly, intelligent biomaterial approaches for targeted drug delivery, combined therapies and targeted modulation of tissue regeneration are of central importance to us in this context.

Key publications

Projects (multicenter)

  • Functional Biomaterials for Controlling Healing Processes in Bone and Skin - From Material Science to Clinical Application; DFG, Transregio Collaborative Research Centre TRR67; subproject B5.
  • Interdisciplinary Innovation Project at Else Kröner-Fresenius-Center for Digital Health (EKFZ). Proof-of-concept for quantitative measurement of capillary refilling time (CRT); partners

Research initiatives

  • MATRESIST: Matrix-Associated Therapy Resistance

Further literature on our hypotheses and approaches


Kontakt

Dr. Sandra Hauser

Wissen­schaftliche Mitarbeiterin
Radio­pharma­zeutische und Chemische Bio­logie
s.hauserAthzdr.de
Tel.: +49 351 260 4046

Prof. Dr. Jens Pietzsch

Abtei­lungs­leiter
Radio­pharma­zeutische und Chemische Bio­logie
j.pietzschAthzdr.de
Tel.: +49 351 260 2622

 
×